| J0897 | Injection, denosumab, 1 mg | 15,960 | $20 | $287.3K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 19,260 | $10 | $192.6K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 6,160 | $30 | $160.1K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 39,210 | $1 | $156.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 950 | $100 | $90K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 9,660 | $10 | $77.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 200 | $110 | $20.9K |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 1,580 | $10 | $11.1K |
| 96372 | A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician… | 580 | $10 | $6.9K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 50 | $130 | $6.9K |